Amelioration of Diabetic Nephropathy Using a Retinoic Acid Receptor β2 Agonist
- 1 October 2018
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 367 (1) , 82-94
Abstract
Vitamin A (VA) and its derivatives, known as retinoids, play critical roles in renal development through retinoic acid receptor β2 (RARβ2). Disruptions in VA signaling pathways are associated with the onset of diabetic nephropathy (DN). Despite the known role of RARβ2 in renal development, the effects of selective agonists for RARβ2 in a high fat diet (HFD) model of DN are unknown. Here we examined whether AC261066 (AC261), a highly selective agonist for RARβ2, exhibited therapeutic effects in a HFD model of DN in C57BL/6 mice. Twelve weeks of AC261 administration to HFD-fed mice was well-tolerated, with no observable side effects. Compared to HFD-fed mice, HFD+AC261 treated mice had improved glycemic control and reductions in proteinuria and urine albumin to creatinine ratio (ACR). A number of cellular hallmarks of DN were mitigated in HFD+AC261 treated mice, including reductions in tubule lipid droplets (LDs), podocyte (POD) effacement, endothelial cell (EC) collapse, mesangial expansion, and glomerular basement membrane (GBM) thickening. Mesangial and tubule interstitial expression of the myofibroblast markers α-smooth muscle actin (α-SMA) and type IV collagen (Col-IV) was lower in HFD+AC261 treated mice compared to HFD alone. Ultrastructural and immunohistochemistry (IHC) analyses showed that, compared to HFD-fed mice, HFD+AC261 treated mice showed preservation of POD foot process and slit diaphragm morphology, an increase in the levels of slit-diagram protein podocin and the transcription factor WT1 in PODs. Given the need for novel DN therapies, our results warrant further studies of the therapeutic properties of AC261 in DN.Keywords
This publication has 98 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Emerging roles for retinoids in regeneration and differentiation in normal and disease statesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathyLaboratory Investigation, 2011
- Role of the retinoic acid receptor-α in HIV-associated nephropathyKidney International, 2011
- Renal lipid metabolism and lipotoxicityCurrent Opinion in Nephrology and Hypertension, 2010
- Retinoic Acid Utilizes CREB and USF1 in a Transcriptional Feed-Forward Loop in Order To Stimulate MKP1 Expression in Human Immunodeficiency Virus-Infected PodocytesMolecular and Cellular Biology, 2008
- Retinoid Regulated Association of Transcriptional Co-regulators and the Polycomb Group Protein SUZ12 with the Retinoic Acid Response Elements of Hoxa1, RARβ2, and Cyp26A1 in F9 Embryonal Carcinoma CellsJournal of Molecular Biology, 2007
- Mutations in STRA6 Cause a Broad Spectrum of Malformations Including Anophthalmia, Congenital Heart Defects, Diaphragmatic Hernia, Alveolar Capillary Dysplasia, Lung Hypoplasia, and Mental RetardationThe American Journal of Human Genetics, 2007
- Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an updateJournal of Clinical Pathology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001